Stay updated on ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Sign up to get notified when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.

Latest updates to the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page
- Check5 days agoChange DetectedThe page’s related topics navigation no longer includes Cystic fibrosis and MedlinePlus Genetics. The core study details remain unchanged.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now includes an additional related topics section entry for *Cystic fibrosis* (via MedlinePlus Genetics). The footer revision is also updated from *v3.5.2* to *v3.5.3*.SummaryDifference0.2%

- Check26 days agoChange DetectedAdded revision note: Revision: v3.5.2. Removed references to cystic fibrosis, related topics, MedlinePlus Genetics, and Revision: v3.5.0.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded related topics: Cystic fibrosis and MedlinePlus Genetics to the related topics section.SummaryDifference0.2%

- Check55 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now shows Revision: v3.4.3, and related-topic links such as Cystic Fibrosis related topics and MedlinePlus Genetics were removed.SummaryDifference0.2%

Stay in the know with updates to ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.